Professor Paul Bowness, Consultant Rheumatologist in Oxford UK, discusses the implications of Cochrane evidence on down-titration and discontinuation of TNFi therapies in Rheumatoid Arthritis.
Sharing health evidence you can trust
Professor Paul Bowness, Consultant Rheumatologist in Oxford UK, discusses the implications of Cochrane evidence on down-titration and discontinuation of TNFi therapies in Rheumatoid Arthritis.